+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hydrocephalus Shunts Market Size, Share & Trends Analysis Report by Product (Valves, Catheter), End-use (Hospitals, Ambulatory Surgical Centers), Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 110 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 5914566
The global hydrocephalus shunts market size is anticipated to reach USD 599.42 million by 2030, registering at a CAGR of 3.99% from 2024 to 2030, according to the report. Growing public and private funding for neurological disorders treatments, increasing clinical studies for the product development, and the rise in regulatory approval for product launch are key contributors to the market growth.

The industry key players are also involved in developing devices for the treatment of hydrocephalus and other neurological disorders. The increasing clinical studies for the product portfolio development further drives the growth of the market. For instance, in October 2023, as part of the ongoing clinical trials evaluating the effectiveness of the device for the treatment of communicating hydrocephalus, CereVasc, Inc. revealed that a milestone 30th patient received the eShunt Implant. The first of these pilot studies, which was carried out in Argentina under regulatory approval from the National Administration of Drugs, Food and Medical Devices (ANMAT), and the second was executed in the U.S. under FDA approval for an Investigational Device Exemption (IDE) to study a minimally invasive treatment for communicating hydrocephalus. Thus, due to such positive outcomes from the clinical studies will drive the market growth in near future.

Hydrocephalus Shunts Market Report Highlights

  • Based on product, valves segment dominated the market in 2023 with a share of 71.26%. Adjustable valves empower healthcare professionals to customize settings according to the patient's specific needs, thereby optimizing the treatment process.
  • The hospitals segment held 75.87% of the overall end user market in 2023. Increasing number of patients being admitted to hospitals due to surgeries, therapies, and treatments is expected to increase the demand for hydrocephalus shunts in near future.
  • North America dominated the overall regional market with the highest revenue share of 37.97% in 2023 owing to high incidence rate of neurological disease & hydrocephalus in this region.
  • Key players in hydrocephalus shunts market include Medtronic, Aesculap, Inc., Spiegelberg GmbH & Co. KG., Integra LifeSciences, Sophysa, CHRISTOPH MIETHKE GMBH & CO. KG, Hpbio, G. Surgiwear Ltd, and Bicakcilar.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Age group outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Hydrocephalus Shunts Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increase in number of patients suffering from hydrocephalus
3.4.1.2. Advancements in shunt technology
3.4.1.3. Growing healthcare awareness
3.4.2. Market restraint analysis
3.4.2.1. Complex regulatory framework
3.5. Hydrocephalus Shunts Market Analysis Tools
3.5.1. Industry Analysis - Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Hydrocephalus Shunts Market: Product Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Valves
4.1.2. Catheter
4.2. Product Market Share, 2023 & 2030
4.3. Segment Dashboard
4.4. Hydrocephalus Shunts Market by Product Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Valves
4.5.1.1. Valves market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Catheter
4.5.2.1. Catheter market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Hydrocephalus Shunts Market: End Use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Ambulatory Surgical Centers
5.2. End Use Market Share, 2023 & 2030
5.3. Segment Dashboard
5.4. Hydrocephalus Shunts Market by End-Use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Ambulatory Surgical Centers
5.5.2.1. Ambulatory surgical centers market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Hydrocephalus Shunts Market: Regional Estimates & Trend Analysis
6.1. Regional market share analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2023
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. Market Age Group, & Forecasts and Trend Analysis, 2018 to 2030
6.6. North America
6.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
6.6.2. U.S.
6.6.2.1. Key country dynamics
6.6.2.2. Competitive scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. U.S. market estimates and forecasts, 2018 - 2030
6.6.3. Canada
6.6.3.1. Key country dynamics
6.6.3.2. Competitive scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Canada market estimates and forecasts, 2018 - 2030
6.7. Europe
6.7.1. UK
6.7.1.1. Key country dynamics
6.7.1.2. Competitive scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement scenario
6.7.1.5. UK market estimates and forecasts, 2018 - 2030
6.7.2. Germany
6.7.2.1. Key Country Dynamics
6.7.2.2. Competitive scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Germany market estimates and forecasts, 2018 - 2030
6.7.3. France
6.7.3.1. Key country dynamics
6.7.3.2. Competitive scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. France market estimates and forecasts, 2018 - 2030
6.7.4. Italy
6.7.4.1. Key country dynamics
6.7.4.2. Competitive scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Italy market estimates and forecasts, 2018 - 2030
6.7.5. Spain
6.7.5.1. Key country dynamics
6.7.5.2. Competitive scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Spain market estimates and forecasts, 2018 - 2030
6.7.6. Denmark
6.7.6.1. Key country dynamics
6.7.6.2. Competitive scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Denmark market estimates and forecasts, 2018 - 2030
6.7.7. Sweden
6.7.7.1. Key country dynamics
6.7.7.2. Competitive scenario
6.7.7.3. Regulatory framework
6.7.7.4. Reimbursement scenario
6.7.7.5. Sweden market estimates and forecasts, 2018 - 2030
6.7.8. Norway
6.7.8.1. Key country dynamics
6.7.8.2. Competitive scenario
6.7.8.3. Regulatory framework
6.7.8.4. Reimbursement scenario
6.7.8.5. Norway market estimates and forecasts, 2018 - 2030
6.8. Asia Pacific
6.8.1. Japan
6.8.1.1. Key country dynamics
6.8.1.2. Competitive scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement scenario
6.8.1.5. Japan market estimates and forecasts, 2018 - 2030
6.8.2. India
6.8.2.1. Key country dynamics
6.8.2.2. Competitive scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement scenario
6.8.2.5. India market estimates and forecasts, 2018 - 2030
6.8.3. China
6.8.3.1. Key country dynamics
6.8.3.2. Competitive scenario
6.8.3.3. Regulatory framework
6.8.3.4. Reimbursement scenario
6.8.3.5. China market estimates and forecasts, 2018 - 2030
6.8.4. South Korea
6.8.4.1. Key country dynamics
6.8.4.2. Competitive scenario
6.8.4.3. Regulatory framework
6.8.4.4. Reimbursement scenario
6.8.4.5. South Korea market estimates and forecasts, 2018 - 2030
6.8.5. Australia
6.8.5.1. Key country dynamics
6.8.5.2. Competitive scenario
6.8.5.3. Regulatory framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Australia market estimates and forecasts, 2018 - 2030
6.8.6. Thailand
6.8.6.1. Key country dynamics
6.8.6.2. Competitive scenario
6.8.6.3. Regulatory framework
6.8.6.4. Reimbursement scenario
6.8.6.5. Thailand market estimates and forecasts, 2018 - 2030
6.9. Latin America
6.9.1. Brazil
6.9.1.1. Key country dynamics
6.9.1.2. Competitive scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement scenario
6.9.1.5. Brazil market estimates and forecasts, 2018 - 2030
6.9.2. Mexico
6.9.2.1. Key country dynamics
6.9.2.2. Competitive scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement scenario
6.9.2.5. Mexico market estimates and forecasts, 2018 - 2030
6.9.3. Argentina
6.9.3.1. Key country dynamics
6.9.3.2. Competitive scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement scenario
6.9.3.5. Argentina market estimates and forecasts, 2018 - 2030
6.10. MEA
6.10.1. South Africa
6.10.1.1. Key country dynamics
6.10.1.2. Competitive scenario
6.10.1.3. Regulatory framework
6.10.1.4. Reimbursement scenario
6.10.1.5. South Africa market estimates and forecasts, 2018 - 2030
6.10.2. Saudi Arabia
6.10.2.1. Key country dynamics
6.10.2.2. Competitive scenario
6.10.2.3. Regulatory framework
6.10.2.4. Reimbursement scenario
6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 - 2030
6.10.3. UAE
6.10.3.1. Key country dynamics
6.10.3.2. Competitive scenario
6.10.3.3. Regulatory framework
6.10.3.4. Reimbursement scenario
6.10.3.5. UAE market estimates and forecasts, 2018 - 2030
6.10.4. Kuwait
6.10.4.1. Key country dynamics
6.10.4.2. Competitive scenario
6.10.4.3. Regulatory framework
6.10.4.4. Reimbursement scenario
6.10.4.5. Kuwait market estimates and forecasts, 2018 - 2030
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Medtronic
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Aesculap, Inc.
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Spiegelberg GmbH & Co. KG.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Integra LifeSciences
7.3.7.1. Company overview
. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Sophysa
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. CHRISTOPH MIETHKE GMBH & CO. KG
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Hpbio
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. G. Surgiwear Ltd
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. Bicakcilar
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global hydrocephalus shunts market, by region 2018 - 2030 (USD Million)
Table 4 Global hydrocephalus shunts market, by product 2018 - 2030 (USD Million)
Table 5 Global hydrocephalus shunts market, by end-use 2018 - 2030 (USD Million)
Table 6 North America hydrocephalus shunts market, by country, 2018 - 2030 (USD Million)
Table 7 North America hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 8 North America hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 9 U.S. hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 10 U.S. hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 11 Canada hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 12 Canada hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 13 Europe hydrocephalus shunts market, by country, 2018 - 2030 (USD Million)
Table 14 Europe hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 15 Europe hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 16 UK hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 17 UK hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 18 Germany hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 19 Germany hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 20 France hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 21 France hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 22 Italy hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 23 Italy hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 24 Spain hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 25 Spain hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 26 Sweden hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 27 Sweden hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 28 Norway hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 29 Norway hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 30 Denmark hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 31 Denmark hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 32 Asia Pacific hydrocephalus shunts market, by country, 2018 - 2030 (USD Million)
Table 33 Asia Pacific hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 34 Asia Pacific hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 35 China hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 36 China hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 37 India hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 38 India hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 39 South Korea hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 40 South Korea hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 41 Australia hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 42 Australia hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 43 Thailand hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 44 Thailand hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 45 Japan hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 46 Latin America hydrocephalus shunts market, by country, 2018 - 2030 (USD Million)
Table 47 Latin America hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 48 Latin America hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 49 Brazil hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 50 Brazil hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 51 Mexico hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 52 Mexico hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 53 Argentina hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 54 Argentina hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa hydrocephalus shunts market, by country, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 57 Middle East & Africa hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 58 South Africa hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 59 South Africa hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 60 Saudi Arabia hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 62 UAE hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 63 UAE hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
Table 64 Kuwait hydrocephalus shunts market, by product, 2018 - 2030 (USD Million)
Table 65 Kuwait hydrocephalus shunts market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Hydrocephalus shunts market: Market snapshot
Fig. 9 Hydrocephalus shunts market: Market segmentation
Fig. 10 Hydrocephalus shunts market Strategy framework
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Hydrocephalus shunts market driver impact
Fig. 14 Hydrocephalus shunts market restraint impact
Fig. 15 Hydrocephalus shunts market Porter’s five forces analysis
Fig. 16 Hydrocephalus shunts market PESTEL analysis
Fig. 17 Hydrocephalus shunts market segment dashboard
Fig. 18 Hydrocephalus shunts market: Product movement Analysis
Fig. 19 Valves market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Catheter market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Hydrocephalus shunts market: End-use movement Analysis
Fig. 22 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Ambulatory surgical centers market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Global hydrocephalus shunts market: Regional movement analysis
Fig. 25 Global hydrocephalus shunts market: Regional outlook and key takeaways
Fig. 26 Global market share, by region
Fig. 27 North America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 Canada market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Europe market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 UK market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Germany market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 France market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Italy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Spain market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Denmark market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Sweden market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Norway market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Japan market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 China market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 India market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Australia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Thailand market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 50 Middle East and Africa. market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 UAE market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 54 Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Companies Profiled

  • Medtronic
  • Aesculap, Inc.
  • Spiegelberg GmbH & Co. KG.
  • Integra LifeSciences
  • Sophysa
  • CHRISTOPH MIETHKE GMBH & CO. KG
  • Hpbio
  • G. Surgiwear Ltd
  • Bicakcilar

Methodology

Loading
LOADING...

Table Information